CLASS II ONGOING Drug recall · Reported 8 Jul 2026 · FDA Enforcement Report

Imuldosa, (ustekinumab-srlf) Injection, 130 mg/ (5mg/mL) recalled

Accord Biopharma is recalling Imuldosa, (ustekinumab-srlf) Injection, 130 mg/ (5mg/mL), distributed nationwide in the US. The recall was initiated on 10 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 004L24A, Exp Date: 02/19/2027.
NDC69448-017, 69448-018, 69448-019
UPC0369448017637, 0369448018634
Quantity recalled326 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0653-2026
FDA event ID
99216
Recalling firm
Accord Biopharma, Raleigh, NC
Manufacturer
Accord BioPharma Inc.
Classification
Class II
Status
Ongoing
Recall initiated
10 Jun 2026
FDA classified
29 Jun 2026
Reported
8 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

10 Jun 2026Recall initiated by company
29 Jun 2026Classified by FDA+19 days
8 Jul 2026Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of Sterility:

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.

Where it was distributed

US Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Lack of assurance of Sterility:

Which lots are affected?

Lot # 004L24A, Exp Date: 02/19/2027.

Where was it sold?

US Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.